Literature DB >> 32576977

ERK signalling: a master regulator of cell behaviour, life and fate.

Hugo Lavoie1, Jessica Gagnon1, Marc Therrien2,3.   

Abstract

The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream components of a phosphorelay pathway that conveys growth and mitogenic signals largely channelled by the small RAS GTPases. By phosphorylating widely diverse substrates, ERK proteins govern a variety of evolutionarily conserved cellular processes in metazoans, the dysregulation of which contributes to the cause of distinct human diseases. The mechanisms underlying the regulation of ERK1 and ERK2, their mode of action and their impact on the development and homeostasis of various organisms have been the focus of much attention for nearly three decades. In this Review, we discuss the current understanding of this important class of kinases. We begin with a brief overview of the structure, regulation, substrate recognition and subcellular localization of ERK1 and ERK2. We then systematically discuss how ERK signalling regulates six fundamental cellular processes in response to extracellular cues. These processes are cell proliferation, cell survival, cell growth, cell metabolism, cell migration and cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32576977     DOI: 10.1038/s41580-020-0255-7

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  260 in total

1.  ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

Authors:  T G Boulton; S H Nye; D J Robbins; N Y Ip; E Radziejewska; S D Morgenbesser; R A DePinho; N Panayotatos; M H Cobb; G D Yancopoulos
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  Subcellular localization determines MAP kinase signal output.

Authors:  Angus Harding; Tianhai Tian; Elizabeth Westbury; Ester Frische; John F Hancock
Journal:  Curr Biol       Date:  2005-05-10       Impact factor: 10.834

Review 3.  Protein kinases: evolution of dynamic regulatory proteins.

Authors:  Susan S Taylor; Alexandr P Kornev
Journal:  Trends Biochem Sci       Date:  2010-10-23       Impact factor: 13.807

Review 4.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

Review 5.  A compendium of ERK targets.

Authors:  Evrim B Ünal; Florian Uhlitz; Nils Blüthgen
Journal:  FEBS Lett       Date:  2017-07-25       Impact factor: 4.124

6.  Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.

Authors:  F Zhang; A Strand; D Robbins; M H Cobb; E J Goldsmith
Journal:  Nature       Date:  1994-02-24       Impact factor: 49.962

Review 7.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

8.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.

Authors:  T G Boulton; G D Yancopoulos; J S Gregory; C Slaughter; C Moomaw; J Hsu; M H Cobb
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

9.  Activity of the MAP kinase ERK2 is controlled by a flexible surface loop.

Authors:  J Zhang; F Zhang; D Ebert; M H Cobb; E J Goldsmith
Journal:  Structure       Date:  1995-03-15       Impact factor: 5.006

Review 10.  Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction.

Authors:  John J M Bergeron; Gianni M Di Guglielmo; Sophie Dahan; Michel Dominguez; Barry I Posner
Journal:  Annu Rev Biochem       Date:  2016-03-24       Impact factor: 23.643

View more
  125 in total

1.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 2.  Allostery, and how to define and measure signal transduction.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Biophys Chem       Date:  2022-01-29       Impact factor: 2.352

3.  Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex.

Authors:  Lena H Nguyen; Steven C Leiser; Dekun Song; Daniela Brunner; Steven L Roberds; Michael Wong; Angelique Bordey
Journal:  Epilepsy Res       Date:  2022-02-18       Impact factor: 3.045

4.  Profiling MAP kinase cysteines for targeted covalent inhibitor design.

Authors:  Ruibin Liu; Neha Verma; Jack A Henderson; Shaoqi Zhan; Jana Shen
Journal:  RSC Med Chem       Date:  2021-11-03

5.  Effects of Subnormothermic Regulated Hepatic Reperfusion on Mitochondrial and Transcriptomic Profiles in a Porcine Model.

Authors:  Joohyun Kim; Michael A Zimmerman; Woo Young Shin; Brent T Boettcher; Ju-Seog Lee; Jong-In Park; Muhammed Ali; Meiying Yang; Jyotsna Mishra; Catherine E Hagen; Joseph E McGraw; Angela Mathison; Harvey J Woehlck; Gwen Lomberk; Amadou K S Camara; Raul A Urrutia; David F Stowe; Johnny C Hong
Journal:  Ann Surg       Date:  2021-08-13       Impact factor: 12.969

6.  PAQR11 modulates monocyte-to-macrophage differentiation and pathogenesis of rheumatoid arthritis.

Authors:  Yijun Lin; Meiqin Huang; Shuo Wang; Xue You; Lingling Zhang; Yan Chen
Journal:  Immunology       Date:  2021-01-24       Impact factor: 7.397

7.  The Role of TRPC6 in Renal Ischemia/Reperfusion and Cellular Hypoxia/Reoxygenation Injuries.

Authors:  Xin Hou; Mengjun Huang; Xixi Zeng; Yanhong Zhang; Anbang Sun; Qifang Wu; Lin Zhu; Hu Zhao; Yanhong Liao
Journal:  Front Mol Biosci       Date:  2021-07-08

8.  A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.

Authors:  Dhirendra K Simanshu; Deborah K Morrison
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 39.397

Review 9.  A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Authors:  Vid Mlakar; Edouard Morel; Simona Jurkovic Mlakar; Marc Ansari; Fabienne Gumy-Pause
Journal:  J Exp Clin Cancer Res       Date:  2021-06-08

Review 10.  Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.

Authors:  Vittoria Infantino; Anna Santarsiero; Paolo Convertini; Simona Todisco; Vito Iacobazzi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.